Target intelligence / Profile preview

Protein phosphatase 1 regulatory subunit 3E (PPP1R3E)

Target
PPP1R3E
Molecular classification
Regulatory subunit/Protein regulator, Enzyme-associated protein (specifically a regulatory subunit of serine/threonine protein phosphatase 1)
01

Overview

Protein phosphatase 1 regulatory subunit 3E is a protein encoded by the *PPP1R3E* gene in humans. It acts as a glycogen-targeting subunit for PP1, a critical regulatory enzyme in glycogen metabolism. PPP1R3E enables PP1 to dephosphorylate and activate glycogen synthase, promoting glycogen synthesis. This process is coordinated by the binding of PPP1R3E to PP1 and its localization to glycogen particles. PPP1R3E is part of a family of more than 100 different PP1 regulatory subunits, which confer substrate specificity and functional diversity to the core phosphatase. Dysfunction of related regulatory subunits has been implicated in metabolic and neurological disorders[4][5][3][9]. - *Note*: While PPP1R3E is less studied than some variants (such as PPP1R3D or GM), its core functional role as a PP1 subunit is established in protein and pathway databases[4][5]. There are currently no drugs targeting PPP1R3E, nor is it established as a routine clinical biomarker. Safety concerns are theoretical and similar to other glycogen metabolism regulators.

Other names
PPP1R3EFLJ00089protein phosphatase 1, regulatory (inhibitor) subunit 3E
02

Mechanism of action

Not established for drugs, but mechanistically PPP1R3E directs PP1 to the glycogen particle, enabling PP1 to dephosphorylate glycogen synthase and phosphorylase, thus regulating glycogen synthesis and breakdown[4][3][9].

03

Biological functions

Glycogen targeting and bindingPositive regulation of glycogen biosynthetic processProtein phosphatase 1 bindingModulation of glycogen synthase activity
04

Disease associations

Myoclonic epilepsy of Lafora 1 (association, possibly via related pathways)Alkhurma hemorrhagic fever (association)Potentially others related to glycogen metabolism and neurodegeneration ("Other")
05

Safety considerations

No direct safety or pharmacological concerns reportedGeneral safety issues with phosphatase regulation involve risk of impaired glucose/glycogen homeostasis and misregulation in metabolic disease

Beyond the preview

Go deeper on Protein phosphatase 1 regulatory subunit 3E (PPP1R3E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 3E (PPP1R3E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call